Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Why don’t we have more Effective Treatment for Keloids? (CROSBI ID 166823)

Prilog u časopisu | stručni rad

Čeović, Romana ; Lipozenčić, Jasna ; Bukvić Mokos, Zrinka ; Štulhofer Buzina, Daška ; Kostović, Krešimir Why don’t we have more Effective Treatment for Keloids? // Acta Dermatovenerologica Croatica, 18 (2010), 3; 195-200

Podaci o odgovornosti

Čeović, Romana ; Lipozenčić, Jasna ; Bukvić Mokos, Zrinka ; Štulhofer Buzina, Daška ; Kostović, Krešimir

engleski

Why don’t we have more Effective Treatment for Keloids?

Numerous treatment modalities have been used to treat keloids and hypertrophic scars, but optimal treatment has not yet been established. The failure of achieving better therapeutic results in treating keloids highlights the essential problem that the pathogenetic mechanisms causing keloids remain unclear. Increased understanding at the molecular level will lead to the development of new therapies. Prevention is the first rule in keloid therapy. Conventional and experimental therapeutic approaches are presented in this review but further investigation is needed in relation to safety, adverse effects, and therapeutic efficacy. Because of the high recurrence rate of keloid scars, a follow-up period of at least 1 year is required to enable the start of treatment of recurrences as expediently as possible and to evaluate long-term success.

keloids; intralesional corticosteroids; excision; radiotherapy;

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

18 (3)

2010.

195-200

objavljeno

1330-027X

Povezanost rada

Kliničke medicinske znanosti

Poveznice
Indeksiranost